Moderate to Severe Rheumatoid Arthritis Clinical Trials

10 clinical trials for Moderate to Severe Rheumatoid Arthritis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING — RECRUITING
• An Extension Study to Evaluate the Long-Term Safety and Efficacy of Afimkibart (RO7790121) in Patients with Rheumatoid Arthritis who Participated in Previous Afimkibart Clinical Trials — RECRUITING · PHASE2
• A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have an Inadequate Response or Intolerance to TNF and/or JAK Inhibitors — RECRUITING · PHASE2
• A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumatoid arthritis — NOT_YET_RECRUITING · PHASE1
• Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis — ACTIVE_NOT_RECRUITING · PHASE3
• A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis — OTHER · PHASE2
• A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug) — OTHER · PHASE2
• MSB11022 in Moderate to Severe Rheumatoid Arthritis — COMPLETED · PHASE3
• Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab — TERMINATED · PHASE4
• Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA — COMPLETED

Refine this search